ArticleFrontiers in cellular and infection microbiology2025
Impact of probiotic-enriched enteral nutrition combined with an ERAS protocol on postoperative recovery and metabolic rehabilitation in laryngeal cancer patients: a single-center retrospective cohort study.
Article in Frontiers in cellular and infection microbiology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Postoperative patients with laryngeal cancer frequently experience nutritional imbalance and complications due to restricted oral intake and inflammatory stress, and a single ERAS or nutritional strategy is insufficient for comprehensive recovery. Objective: To evaluate the effect of probiotic-enhanced enteral nutrition combined with an ERAS nursing pathway on postoperative gastrointestinal function, inflammatory-nutritional response, and medical resource utilization in patients with laryngeal cancer. Methods: A total of 312 single-center laryngeal cancer cases from 2021-2024 were retrospectively enrolled. After 1:1 propensity-score matching, the experimental group (n = 132, probiotics + ERAS) was compared with the control group (n = 132, routine care). The primary outcome was time to first flatus. Secondary outcomes included inflammatory-nutritional indices, complications, hospital resources, and readmission. Statistical analyses used the Cox model, linear mixed-effects model, robust variance Poisson regression, Gamma-GLM, and Pearson correlation. Results: On postoperative days 1-3, energy and protein intake were significantly higher in the experimental group than in controls (both P< 0.001); a significant group × time interaction for 7-day cumulative target attainment was also observed (P< 0.001). The probability of first flatus increased by 98% (HR = 1.98 [1.55-2.52], P< 0.001). Within 72 h, rises in CRP, IL-6, and leukocyte count and declines in albumin and prealbumin were all significantly smaller in the experimental group (group × time interactions, all P< 0.001). Risks of Clavien-Dindo grade ≥ II complications, pneumonia, wound infection, and pharyngocutaneous fistula were markedly reduced (RR 0.25-0.39, P< 0.05). Median postoperative length of stay and antibiotic days fell by 3.21 and 2.48 days, respectively; cost ratio was 0.83 (0.79-0.88); 30-day readmission OR was 0.32 (0.12-0.83). ERAS adherence correlated inversely with length of stay (r = -0.59; β = -0.017; P< 0.001). Conclusion: Probiotic-enhanced enteral nutrition combined with ERAS accelerates gastrointestinal recovery, suppresses inflammation, maintains nutritional status, and significantly reduces complications and healthcare burden in the perioperative period of laryngeal cancer, supporting the integrated "micro-ecology-nutrition-process" model as an effective strategy for rapid recovery in head-and-neck surgery.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.